These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 9783700)

  • 1. Clinical features, molecular genetics, and pathophysiology of dominant optic atrophy.
    Votruba M; Moore AT; Bhattacharya SS
    J Med Genet; 1998 Oct; 35(10):793-800. PubMed ID: 9783700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic heterogeneity of dominant optic atrophy, Kjer type: Identification of a second locus on chromosome 18q12.2-12.3.
    Kerrison JB; Arnould VJ; Ferraz Sallum JM; Vagefi MR; Barmada MM; Li Y; Zhu D; Maumenee IH
    Arch Ophthalmol; 1999 Jun; 117(6):805-10. PubMed ID: 10369594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No evidence of genetic heterogeneity in dominant optic atrophy.
    Bonneau D; Souied E; Gerber S; Rozet JM; D'Haens E; Journel H; Plessis G; Weissenbach J; Munnich A; Kaplan J
    J Med Genet; 1995 Dec; 32(12):951-3. PubMed ID: 8825922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of a founder effect and fine mapping of dominant optic atrophy locus on 3q28-qter by linkage disequilibrium method: a study of 38 British Isles pedigrees.
    Votruba M; Moore AT; Bhattacharya SS
    Hum Genet; 1998 Jan; 102(1):79-86. PubMed ID: 9490303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hereditary optic atrophies].
    Scherer C; Procaccio V; Ferre M; Guillet V; Reynier P; Amati-Bonneau P; Dubas F; Bonneau D; Verny C
    Rev Neurol (Paris); 2010 Dec; 166(12):959-65. PubMed ID: 21056443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refinement of the dominant optic atrophy locus (OPA1) to a 1.4-cM interval on chromosome 3q28-3q29, within a 3-Mb YAC contig.
    Jonasdottir A; Eiberg H; Kjer B; Kjer P; Rosenberg T
    Hum Genet; 1997 Jan; 99(1):115-20. PubMed ID: 9003507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant optic atrophy (OPA1) mapped to chromosome 3q region. I. Linkage analysis.
    Eiberg H; Kjer B; Kjer P; Rosenberg T
    Hum Mol Genet; 1994 Jun; 3(6):977-80. PubMed ID: 7951248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetic basis of primary inherited optic neuropathies.
    Votruba M
    Eye (Lond); 2004 Nov; 18(11):1126-32. PubMed ID: 15534598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features in affected individuals from 21 pedigrees with dominant optic atrophy.
    Votruba M; Fitzke FW; Holder GE; Carter A; Bhattacharya SS; Moore AT
    Arch Ophthalmol; 1998 Mar; 116(3):351-8. PubMed ID: 9514489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse models of dominant optic atrophy: what do they tell us about the pathophysiology of visual loss?
    Williams PA; Morgan JE; Votruba M
    Vision Res; 2011 Jan; 51(2):229-34. PubMed ID: 20801145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of primary hereditary optic neuropathies.
    Votruba M; Aijaz S; Moore AT
    J Inherit Metab Dis; 2003; 26(2-3):209-27. PubMed ID: 12889662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and genetic analysis of a family affected with dominant optic atrophy (OPA1).
    Brown J; Fingert JH; Taylor CM; Lake M; Sheffield VC; Stone EM
    Arch Ophthalmol; 1997 Jan; 115(1):95-9. PubMed ID: 9006432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological findings in dominant optic atrophy (DOA) linking to the OPA1 locus on chromosome 3q 28-qter.
    Holder GE; Votruba M; Carter AC; Bhattacharya SS; Fitzke FW; Moore AT
    Doc Ophthalmol; 1998-1999; 95(3-4):217-28. PubMed ID: 10532406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic refinement of dominant optic atrophy (OPA1) locus to within a 2 cM interval of chromosome 3q.
    Votruba M; Moore AT; Bhattacharya SS
    J Med Genet; 1997 Feb; 34(2):117-21. PubMed ID: 9039986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refinement of the locus for autosomal dominant juvenile optic atrophy to a 2 cM region on 3q28.
    Stoilova D; Child A; Desai SP; Sarfarazi M
    Ophthalmic Genet; 1997 Mar; 18(1):1-6. PubMed ID: 9134544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary optic neuropathies share a common mitochondrial coupling defect.
    Chevrollier A; Guillet V; Loiseau D; Gueguen N; de Crescenzo MA; Verny C; Ferre M; Dollfus H; Odent S; Milea D; Goizet C; Amati-Bonneau P; Procaccio V; Bonneau D; Reynier P
    Ann Neurol; 2008 Jun; 63(6):794-8. PubMed ID: 18496845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dominant optic atrophy mapped to chromosome 3q region. II. Clinical and epidemiological aspects.
    Kjer B; Eiberg H; Kjer P; Rosenberg T
    Acta Ophthalmol Scand; 1996 Feb; 74(1):3-7. PubMed ID: 8689476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OPA1 gene therapy prevents retinal ganglion cell loss in a Dominant Optic Atrophy mouse model.
    Sarzi E; Seveno M; Piro-Mégy C; Elzière L; Quilès M; Péquignot M; Müller A; Hamel CP; Lenaers G; Delettre C
    Sci Rep; 2018 Feb; 8(1):2468. PubMed ID: 29410463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant Optic Atrophy and Leber's Hereditary Optic Neuropathy: Update on Clinical Features and Current Therapeutic Approaches.
    Chun BY; Rizzo JF
    Semin Pediatr Neurol; 2017 May; 24(2):129-134. PubMed ID: 28941528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical and transcript map of the dominant optic atrophy (OPA1) gene critical region at 3q28-q29.
    Behnam JT; Hamer C; Spalton D; Johnston R; Seller MJ
    Genomics; 2001 Mar; 72(2):213-6. PubMed ID: 11401435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.